Date updated:01-21-2007
Abby Joseph Cohen is the well known partner and chief U.S. investment strategist at Goldman Sachs. She is famous for predicting the bull market of the 1990s early in the decade. However, she failed to predict the dramatic stock market decline of the early 2000s and developed a reputation as a so-called "perpetual bull".
From Barrons Roundtable 1-22-07
"The great bull market has come and gone, but Abby Cohen, Goldman Sachs' unflappable U.S. investment strategist, remains, explaining the post-bubble world as expertly as she discoursed on its manic predecessor. Abby's not a stockpicker but a stock peruser, scanning Goldman's Buy list for companies that amplify her ideas. The U.S. consumer has yet to fall down on the job, which should benefit cruise-line operator Royal Caribbean and Federated Department Stores. The government's efforts to contain health-care costs should bolster generic-drug makers such as Barr Pharmaceuticals. You get the picture. You'll also get the good word on General Electric, currently one of her favorites."

-
GE
Gen Electric Co - $15.33
- +6.24%
- $14.98
"GE is notably underweighted versus the S&P. That means portfolio managers, to this point, have decided the company is going to underperform. We don't think so...At a time when the economic cycle is getting a little old, this is a company with annual earnings growth of 9%. We have confidence around that number. Return on equity is about 16%. The current price-earnings multiple based on 2007 results is about 17 times earnings."

-
RCL
Royal Caribbean C - $21.23
- -1.35%
- $20.92
"This is not a budget cruise line. In this higher-income demographic, compensation and household incomes are rising. ...In '07 there could be a substantial increase in the company's revenue, on the order of 13% or 14%. Earnings, which were flattish in '06, could go up about 8%. At 13 times earnings, the stock sells at a discount to its competitors."

-
FD
Fd - $0.00
- N/A
- $N/A
"the shares currently trade for about 18 times fiscal '07 earnings and 13 times the next fiscal year. It is reasonably priced and has good prospects for earnings and margins."

-
MEDI
Medi - $0.00
- N/A
- $N/A
"MedImmune [MEDI] is a specialty pharmaceuticals company. It markets FluMist, which is distributed not only in the U.S., but increasingly overseas. It has been a significant player in the HPV [human papilloma virus] vaccine, which represents one of the truly dramatic changes in public health care. The vaccine has been seen to affect the virus, and therefore eliminate a form of cancer, which is quite extraordinary. The P/E is high, but earnings are about to grow dramatically. Long-term earnings growth is about 18%. "

-
BRL
N/a - $64.81
- 0.00
- $64.81
"The P/E based on 2007 earnings is about 15...We estimate Barr will do $3.51 a share this year, versus $3.13 in '06. The consensus for '06 was $3.09, and for this year is $3.39, so we're above consensus."

-
BHI
Baker Hughes Intl - $41.18
- -2.23%
- $41.40
"The stock is selling at a discount to some of its peers, like Schlumberger [SLB], in part because of some execution problems at Baker Oil Tools. Our analyst believes the problem will be rectified. The P/E based on this year's earnings is about 13. That is not an unreasonable price to pay for a good, long-term investment."

-
SYMC
Symantec Corporat - $17.42
- -0.17%
- $17.35
"The stock sells for about 18 times 2007 earnings. Clearly, P/Es are not what they used to be in this category. The stock performed roughly in line with the overall market in 2006, but longer-term earnings growth is on the order of 16%-17%, which is substantially better than the S&P 500. "
- Top Professional Portfolios
- 1. Navellier & Associ...
- 2. Fidelity Contrafund - ...
- 3. Argus Management
- 4. Charlie Munger
- 5. Calamos Advisors
- show all
- Top Do-It-Yourself Portfolios
- » Joy
- » tsamanuli Portfolio 1
- » Albo's First Portfolio
- » Fundsonly Portfolio 1
- » rk00005
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...
By Roberto Pedone Posted on Nov. 5, 2009 The traders on CNBC’s “Fast Money” told their viewers what they must know after Warren Buffett announced on Tuesday his l...
By Jonas Elmerraji Posted on Nov. 4, 2009 For investors who seek out short-squeeze opportunities, there’s no time as important as earnings season. Earnings are one of...
By Stockpickr Staff Posted on Nov. 4, 2009 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is...
A. The only one I own : SLX,
too hard pick a winner out all of them
Analyst Upgrades for Nov. 2, 2009. Read more here. more
These are the stocks from Jim Cramer's Oct. 30 Lightning Round. We list the stocks on which he is BULLISH and BEARISH.... more
Here is a list of some of the biggest stocks that hit 52-week lows on Nov. 2, 2009. more











Comments not available